SOCIETY OF HEMATOLOGIC ONCOLOGY (EIN 461923333) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Tax Period

2023-01-01 to 2023-12-31

SOCIETY OF HEMATOLOGIC ONCOLOGY, founded in 2012, is a small nonprofit in the Medical Research sector that reported $402K in total revenue in fiscal year 2023. Revenue surged 101% from the prior year, signaling strong growth momentum. The organization ran a surplus of $202K, a strong 50% operating margin.

Mission

PROMOTE WORLDWIDE RESEARCH EDUCATION, PREVENTION, CLINICAL STUDIES AND OPTIMAL PATIENT CARE IN ALL ASPECTS OF HEMATOLOGIC ONCOLOGY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $200,000

Program Service Revenue $202,335

Investment Income $0

Other Revenue $0

TOTAL REVENUE $402,335

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $200,000

Other Expenses $200,000

TOTAL EXPENSES $200,000

Year-over-Year Comparison

	2023	2022	Change
Revenue	$402,335	$200,000	+1.0%
Expenses	$200,000	$200,000	N/A
Net Income	$202,335	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
DIETER HOELZER	PAST-PRESIDENT	Director	$0	$0	$0
CHING-HON PUI	PAST-PRESIDENT	Director	$0	$0	$0
ANTHONY H GOLDSTONE	PAST-PRESIDENT	Director	$0	$0	$0
JULIE VOSE	MEMBER	Director	$0	$0	$0
ALAN F LIST	PAST-PRESIDENT	Director	$0	$0	$0
SUSAN OBRIEN	PAST PRESIDENT	Director	$0	$0	$0
SAGAR LONIAL	PAST-PRESIDENT	Director	$0	$0	$0
JANET CESAK	MANAGING DIRECTOR NON-VOTING	Officer	$0	$0	$0
GUILLERMO GARCIA-MANERO	PRESIDENT ELECT	Officer	$0	$0	$0
MOSHE TALPAZ	IMMEDIATE PAST PRESIDENT	Officer	$0	$0	$0
HAGOP KANTARJIAN	SECRETARY	Officer	$0	$0	$0
JENNIFER BROWN	PRESIDENT & CHAIR OF THE BOAR	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$402,335	$200,000	$211,400	$202,335
2022	$200,000	$200,000	$9,065	No data

SOCIETY OF HEMATOLOGIC ONCOLOGY